Fig. 2
From: A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
DCZ0805 arrests the cell cycle at G0/G1 phase in MM cells. a H929 and ARP-1 cells were treated with DCZ0805 (0, 10 and 20 µM) for 24 h, stained with PI and analyzed by flow cytometry. Bar graphs show the percentage of cells in the G0/G1, S and G2/M phases of the cell cycle. *P < 0.05 compared with the control group (G0/G1 stage). b Western blot analysis of the protein expression levels of cyclin D1, CDK4, and CDK6, with β-actin used as an internal reference index